CyVec: A Novel Delivery
Platform

CyVec platform is a proprietary engineered negatively charged protein molecule that deterministically translocates through the cell membrane using a non- endocytic, helical mechanism. It is a non-toxic, low immunogenic carrier platform for therapeutically valuable cargoes.

CyVec effectively transfers small molecules (e.g. chemotherapeutics), larger biomolecules (e.g. proteins) and small oligonucleotides across the cellular membrane of different cell types.

Key Advantages of CyVec:

Delivers Functional Biomolecules including proteins and nucleotides.

Universal Carrier for various cell types including primary cells (e.g. stem cells)

Can selectively deliver to intracellular targets (e.g. Nucleus) and specific cell types (e.g. HER2+ expressing cells).

Non-toxic and low immunogenicity

Application of CyGenica's technology in the intracellular delivery of gene editing toolbox

2nd Video- Application of CyGenica's technology in the intracellular delivery of anti cancer drugs

CyGenica's Delivery Statergy

  • Step 1
    Target Specificity by recognizing cell type receptors
  • Step 2
    Entry through the target cell membrane
  • Step 3
    Entry To The nucleus of the target nucleus

CyGenica’s CyVec platform is a proprietary engineered negatively charged molecule that works just like a molecular drill boring through the cell membrane to deliver molecular cargoes to the nucleus without causing any harm to the cell, solving the most crucial issue of targeted intracellular delivery. CyVec can be used to develop in vitro and in vivo delivery mechanisms for drugs, gene editing mechanisms and antibiotics.

Interested in collaborating with us? You can reach us on social media or through our contact form.

CONNECT

©️ 2021 CYGENICA. ALL RIGHTS RESERVE. | TERMS OF USE

Developed by: Malus Technology